Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma (MM) patients with relapsing and/or refractory (RR) disease are exposed for a prolonged time to multiple drugs, which increase the risk of toxicity. In addition to tumor response, preserving the quality of life represents an important goal for this patient population...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozzi, Samantha, Bari, Alessia, Pecherstorfer, Martin, Vallet, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508369/
https://www.ncbi.nlm.nih.gov/pubmed/34638462
http://dx.doi.org/10.3390/cancers13194978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508369/
https://www.ncbi.nlm.nih.gov/pubmed/34638462
http://dx.doi.org/10.3390/cancers13194978

Ejemplares similares